Diartis Pharmaceuticals Closes VC Round
Diartis Pharmaceuticals Inc. has raised an undisclosed amount of financing from Index Ventures, biotechnology company Amunix Inc. and other, undisclosed investors. Mountain View, Calif.-based Diartis is a biotechnology company developing therapeutics for the treatment of metabolic diseases.
16 February 2011•3 mins read
